Stocks Health care BHC
NYSE · Health careBausch Health Companies Inc. (BHC)
Bausch Health Companies Inc. brought in $11.1B of revenue over the twelve months to September 30, 2026, up 10.8% from a year earlier. It posted a net loss of $841M. Operating cash flow minus capital spending left $1B of free cash flow in fiscal 2025. At September 30, 2026 it held $2.5B in cash against $20.6B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 29, 2026.
Key facts about Bausch Health Companies Inc.
- Net worth
- Bausch Health Companies Inc. has a market value (market cap) of $3.1B at the latest share price, and shareholders' equity of -$1.3B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $10.3B (+6.7% year on year), with net income of $157M. Over the 12 months to September 30, 2026: revenue $11.1B, net loss $841M.
- Cash flow
- In fiscal 2025 operations brought in $1.4B of cash; after $397M of capital spending, free cash flow was $1B.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 29, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Bausch Health Companies Inc.'s next report is expected around January 12, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- Bausch Health Companies Inc. declared dividends of $1.28 per share in fiscal 2010.
What Bausch Health Companies Inc. does
Bausch Health Companies Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker BHC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $10.3B | $157M | $0.42 | $1B |
| 2024 | $9.6B | -$46M | -$0.13 | $1.3B |
| 2023 | $8.8B | -$592M | -$1.62 | $817M |
| 2022 | $8.1B | -$225M | -$0.62 | -$946M |
| 2021 | $8.4B | -$948M | -$2.64 | $1.2B |
| 2020 | $8B | -$560M | -$1.58 | $809M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where BHC ranks in Health care
Dividends
Bausch Health Companies Inc. declared $1.28 per share in fiscal 2010. It paid out $356.3M in cash dividends.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2010 | $1.28 | $356.3M | n/a |
| 2010 | $0.65 | $147.1M | n/a |
| 2008 | $1.50 | $180.3M | n/a |
Latest SEC filings
What Bausch Health Companies Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 29, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 9.7% to $2.9B versus the same quarter last year; diluted EPS $1.15 versus $0.48.
- October 28, 2026
- July 30, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 13% to $2.9B versus the same quarter last year; diluted EPS $0.68 versus $0.40.
- July 29, 2026
- July 1, 2026
- June 1, 2026
- May 19, 2026
- April 30, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 12% to $2.5B versus the same quarter last year; diluted EPS -$3.82 versus -$0.16.
- April 29, 2026
- April 8, 2026
What is BHC worth? A DCF from its reported cash flow
Insider trades
What the people running Bausch Health Companies Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $258.9K worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 30, 2026 | Wechsler Amy BDirector | Received as pay | 1,179 | $6.9K |
| September 30, 2026 | Leung SandraDirector | Received as pay | 5,789 | $33.7K |
| September 30, 2026 | Paulson JohnDirector | Received as pay | 10,720 | $62.5K |
| August 19, 2026 | Lenar Aimee J.President, US Pharma | Soldpre-planned (10b5-1) | 36,827 | $258.9K |
| July 17, 2026 | Lenar Aimee J.President, US Pharma | Shares withheld for tax | 5,260 | $25.4K |
| July 15, 2026 | Lenar Aimee J.President, US Pharma | Shares withheld for tax | 23,395 | $114.4K |
| July 14, 2026 | Lee Steven HyosigSVP, Controller & CAO | Shares withheld for tax | 3,125 | $14.8K |
| June 30, 2026 | Leung SandraDirector | Received as pay | 6,845 | $33.7K |
Who owns BHC
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Paulson & Co. Inc.13D, may seek influence | 19.1% | August 14, 2025 |
| Alex Meruelo13D, may seek influence | 9.99% | April 7, 2025 |
| Icahn Capital LP13D, may seek influence with 9 related filers | 9.51% | February 7, 2024 |
| Steven A. Tananbaum13G, passive with 2 related filers | 9.5% | August 14, 2025 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 220 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Paulson & Co. Inc. | 73,255,869 | 0 |
| Goldentree Asset Management LP | 34,665,731 | 0 |
| Royal Bank of Canada | 10,832,582 | -530,916 |
| Healthcare of Ontario Pension Plan Trust Fund | 8,000,000 | 0 |
| Vanguard Capital Management LLC | 7,465,468 | +61,709 |
| Geode Capital Management, LLC | 4,803,485 | +574,614 |
| Goldman Sachs Group Inc | 6,225,131 | +1,017,165 |
| MFN Partners Management, LP | 6,000,000 | 0 |
| Kohlberg Kravis Roberts & Co. L.P. | 5,235,000 | 0 |
| Ing Groep NV | 5,000,000 | 0 |
| Hudson Bay Capital Management LP | 5,000,000 | 0 |
| Gendell Jeffrey L | 4,037,091 | +1,067,251 |
| Norges Bank | 3,431,117 | new |
| Macquarie Group Ltd | 3,250,000 | 0 |
| Dimensional Fund Advisors LP | 3,241,140 | -363,678 |
| D. E. Shaw & Co., Inc. | 2,689,942 | +2,068,187 |
| Vanguard Fiduciary Trust Co | 2,250,910 | +29,745 |
| Point72 Asset Management, L.P. | 2,235,821 | +885,559 |
| Charles Schwab Investment Management Inc | 2,186,244 | -23,323 |
| Two Sigma Investments, LP | 2,135,582 | +557,421 |
Insiders
15 insiders reported holding 79,094,931 shares in total, about $664.4M at the last price.
| Holder | Shares |
|---|---|
| Paulson & Co. Inc.10% owner | 73,255,86973,255,869 held indirectly |
| Appio ThomasChief Executive Officer, Director | 2,315,374 |
| Charhon Jean-JacquesEVP, CFO | 706,478 |
| Carson SeanaEVP, General Counsel | 616,761 |
| Paulson JohnDirector | 440,962 |
| Lenar Aimee J.President, US Pharma | 334,853 |
| Wechsler Amy BDirector | 316,158 |
| Power Robert NDirector | 300,594 |
| Kavanagh Sarah BDirector | 282,230 |
| Garcia Christian ADirector | 135,578 |
Questions about BHC
What does Bausch Health Companies Inc. do?
Bausch Health Companies Inc. is a company in the Health care sector, listed on NYSE as BHC. Its shares trade on NYSE under the ticker BHC.
What is Bausch Health Companies Inc.'s net worth?
Bausch Health Companies Inc. has a market value (market cap) of $3.1B at the latest share price, and shareholders' equity of -$1.3B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Bausch Health Companies Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $841M on revenue of $11.1B.
How much revenue does Bausch Health Companies Inc. make?
Over the twelve months to September 30, 2026 Bausch Health Companies Inc. reported revenue of $11.1B. That is 10.8% more than a year earlier.
When did Bausch Health Companies Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 29, 2026. It covers the period to September 30, 2026.
When is Bausch Health Companies Inc.'s next earnings report?
Bausch Health Companies Inc.'s next report is expected around January 12, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Does Bausch Health Companies Inc. pay a dividend?
Yes. Bausch Health Companies Inc. declared dividends of $1.28 per share in fiscal 2010.
Similar companies
Compare BHC with
Follow BHC
Get an email when Bausch Health Companies Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Bausch Health Companies Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.